Family reflects on extra months gained from new pancreatic cancer drug daraxonrasib
read at STAT ↗Positive
Bobby Senaha was among the first patients to receive daraxonrasib, a new medicine aimed at extending survival for people with pancreatic cancer.
The drug is described as life extending, offering patients additional time beyond what standard treatments provide.
His wife described how those extra months allowed the family to create more memories, plan for the future, and experience moments they might otherwise have missed.
source
This writeup was produced by pharmadog from original reporting by STAT. The original article may no longer be reachable at its published URL.
Original headline: “One family’s story of a life-extending medicine for pancreatic cancer”
read at STAT ↗
comments(0)
5-min edit window · permanent after that